Budget 2026: Sitharaman proposes ₹10,000 crore investment in biopharma over next 5 years – The Hindu

Budget 2026: Sitharaman proposes ₹10,000 crore investment in biopharma over next 5 years  The HinduUnion Budget 2026: How Import Duty Exemption On Rare Disease Drugs Could Make Treatments Cheaper  NDTVBudget 2026-27: List of 17 cancer drugs exempted from customs duty  India TodayUnion Budget 2026: Health education gets a structural reset from biopharma labs to mental health institutes  Times of IndiaUnion Budget 2026-27: Rs 10,000 crore allocated for Bio Pharma Shakti scheme  The News Minute  Read More